Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...

Pfizer has partnered with Summit Therapeutics to evaluate ivonescimab, a PD-1/VEGF bispecific antibody, in combination with ...

The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...

Summit’s PD-1 bispecific antibody outperformed MSD’s Keytruda in a Phase III trial enrolling patients with lung cancer.

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief ...

Onge, Minister of Canadian Heritage, announced the appointment of Cheryl Hickman as the next chairperson of the Canada Council for the Arts for a five-year term. Ms. Hickman currently serves as a ...

Booking Holdings today announced that Chief Financial Officer Ewout Steenbergen will participate in a fireside chat at the Morgan Stanley Technology, Media & Telecom Conference, held in San Francisco, ...

President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.

Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the TD Cowen 45 th Annual Health ...

Pfizer CEO Dr. Albert Bourla was loudly booed during a White House Black History Month event where he was introduced by President Trump.

The public detente between President Donald Trump and Big Tech titans, forged in the wake of his return to power, has yet to ...

Pfizer CEO Albert Bourla supports Trump administration at PhRMA Forum, while CDC postpones vaccine advisory meeting. Atomwise names Steve Worland as CEO, and Biogen licenses Dravet drug.